Android app Apple app link

FDA Approves GSK's 5-in-1 Meningococcal Vaccine For Adolescents Ahead Of CDC Advisory Committee Vote Meeting Next Week

By Yahoo! Finance   |   1 month ago
FDA Approves GSK's 5-in-1 Meningococcal Vaccine For Adolescents Ahead Of CDC Advisory Committee Vote Meeting Next Week

The FDA approved GSK's Penmenvy vaccine targeting 5 meningococcal groups. The vaccine combines antigens from Bexsero and Menveo vaccines. GSK expects to lead the U.S. market in meningococcal vaccinations.

Read More

Did you find this insightful?

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.